[1]
|
中华医学会内分泌学分会. 原发性醛固酮增多症诊断治疗的专家共识(2020版) [J]. 中华内分泌代谢杂志, 2020, 36(9): 727-736.
|
[2]
|
Buffolo, F., Monticone, S., Burrello, J., et al. (2017) Is Primary Aldosteronism Still Largely Unrecognized? Hormone and Metabolic Research, 49, 908-914. https://doi.org/10.1055/s-0043-119755
|
[3]
|
Monticone, S., Burrello, J., Tizzani, D., et al. (2017) Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. Journal of the American College of Cardiology, 69, 1811-1820. https://doi.org/10.1016/j.jacc.2017.01.052
|
[4]
|
Käyser, S.C., Dekkers, T., Groenewoud, H.J., et al. (2016) Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis. The Journal of Clinical Endocrinology & Metabolism, 101, 2826-2835. https://doi.org/10.1210/jc.2016-1472
|
[5]
|
Mulatero, P., Sechi, L.A., Williams, T.A., et al. (2020) Subtype Diagnosis, Treatment, Complications and Outcomes of Primary Aldosteronism and Future Direction of Research: A Position Statement and Consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. Journal of Hypertension, 38, 1929-1936. https://doi.org/10.1097/HJH.0000000000002520
|
[6]
|
Buffolo, F., Tetti, M., Mulatero, P., et al. (2022) Aldosterone as a Mediator of Cardiovascular Damage. Hypertension, 79, 1899-1911. https://doi.org/10.1161/HYPERTENSIONAHA.122.17964
|
[7]
|
Brown, N.J. (2008) Aldosterone and Vascular Inflammation. Hypertension, 51, 161-167. https://doi.org/10.1161/HYPERTENSIONAHA.107.095489
|
[8]
|
Luther, J.M. (2014) Effects of Aldosterone on Insulin Sensitivity and Secretion. Steroids, 91, 54-60. https://doi.org/10.1016/j.steroids.2014.08.016
|
[9]
|
Santana, L.S., Guimaraes, A.G. and Almeida, M.Q. (2022) Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome. Frontiers in Endocrinology, 13, Article 927669. https://doi.org/10.3389/fendo.2022.927669
|
[10]
|
Boulkroun, S., Beuschlein, F., Rossi, G.P., et al. (2012) Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism. Hypertension, 59, 592-598. https://doi.org/10.1161/HYPERTENSIONAHA.111.186478
|
[11]
|
Fernandes-Rosa, F.L., Williams, T.A., Riester, A., et al. (2014) Genetic Spectrum and Clinical Correlates of Somatic Mutations in Aldosterone-Producing Adenoma. Hypertension, 64, 354-361. https://doi.org/10.1161/HYPERTENSIONAHA.114.03419
|
[12]
|
Zheng, F.F., Zhu, L.M., Nie, A.F., et al. (2015) Clinical Characteristics of Somatic Mutations in Chinese Patients with Aldosterone-Producing Adenoma. Hypertension, 65, 622-628. https://doi.org/10.1161/HYPERTENSIONAHA.114.03346
|
[13]
|
Hong, A.R., Kim, J.H., Song, Y.S., et al. (2016) Genetics of Aldosterone-Producing Adenoma in Korean Patients. PLOS ONE, 11, e0147590. https://doi.org/10.1371/journal.pone.0147590
|
[14]
|
Wu, V.C., Huang, K.H., Peng, K.Y., et al. (2015) Prevalence and Clinical Correlates of Somatic Mutation in Aldosterone Producing Adenoma-Taiwanese Population. Scientific Reports, 5, Article No. 11396. https://doi.org/10.1038/srep11396
|
[15]
|
Kitamoto, T., Suematsu, S., Matsuzawa, Y., et al. (2015) Comparison of Cardiovascular Complications in Patients with and without KCNJ5 Gene Mutations Harboring Aldosterone-Producing Adenomas. Journal of Atherosclerosis and Thrombosis, 22, 191-200. https://doi.org/10.5551/jat.24455
|
[16]
|
Nanba, K., Yamazaki, Y., Bick, N., et al. (2020) Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients. The Journal of Clinical Endocrinology & Metabolism, 105, e4066-e4073. https://doi.org/10.1210/clinem/dgaa595
|
[17]
|
Nanba, K., Omata, K., Gomez-Sanchez, C.E., et al. (2019) Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks. Hypertension, 73, 885-892. https://doi.org/10.1210/jc.2015-2149
|
[18]
|
Lenzini, L., Rossitto, G., Maiolino, G., et al. (2015) A Meta-Analysis of Somatic KCNJ5 K Channel Mutations in 1636 Patients with an Aldosterone-Producing Adenoma. The Journal of Clinical Endocrinology & Metabolism, 100, E1089-E1095. https://doi.org/10.1210/jc.2015-2149
|
[19]
|
Okamura, T., Nakajima, Y., Katano-Toki, A., et al. (2017) Characteristics of Japanese Aldosterone-Producing Adenomas with KCNJ5 Mutations. Endocrine Journal, 64, 39-47. https://doi.org/10.1507/endocrj.EJ16-0243
|
[20]
|
Brilla, C.G. and Weber, K.T. (1992) Reactive and Reparative Myocardial Fibrosis in Arterial Hypertension in the Rat. Cardiovascular Research, 26, 671-677. https://doi.org/10.1093/cvr/26.7.671
|
[21]
|
de Simone, G., Verdecchia, P., Pede, S., et al. (2002) Prognosis of Inappropriate Left Ventricular Mass in Hypertension: The MAVI Study. Hypertension, 40, 470-476. https://doi.org/10.1161/01.HYP.0000034740.99323.8A
|
[22]
|
Rossi, G.P., Sacchetto, A., Visentin, P., et al. (1996) Changes in Left Ventricular Anatomy and Function in Hypertension and Primary Aldosteronism. Hypertension, 27, 1039-1045. https://doi.org/10.1161/01.HYP.27.5.1039
|
[23]
|
Rossi, G.P., Cesari, M., Cuspidi, C., et al. (2013) Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy with Treatment of Primary Aldosteronism. Hypertension, 62, 62-69. https://doi.org/10.1161/HYPERTENSIONAHA.113.01316
|
[24]
|
Wang, B., Li, X., Zhang, X., et al. (2015) Prevalence and Characterization of Somatic Mutations in Chinese Aldosterone-Producing Adenoma Patients. Medicine (Baltimore), 94, e708. https://doi.org/10.1097/MD.0000000000000708
|
[25]
|
Chang, Y.Y., Tsai, C.H., Peng, S.Y., et al. (2021) KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated with a Worse Baseline Status and Better Recovery of Left Ventricular Remodeling and Diastolic Function. Hypertension, 77, 114-125. https://doi.org/10.1161/HYPERTENSIONAHA.120.15679
|
[26]
|
胡君丽, 洪静, 吴婷, 等. 原发性醛固酮增多症患者KCNJ5基因变异对其心脏的损害作用[J]. 中国医药导报, 2019, 16(8): 63-67.
|
[27]
|
Kitamoto, T., Omura, M., Suematsu, S., et al. (2018) KCNJ5 Mutation as a Predictor for Resolution of Hypertension after Surgical Treatment of Aldosterone-Producing Adenoma. Journal of Hypertension, 36, 619-627. https://doi.org/10.1097/HJH.0000000000001578
|
[28]
|
Lacolley, P., Labat, C., Pujol, A., et al. (2002) Increased Carotid Wall Elastic Modulus and Fibronectin in Aldosterone-Salt-Treated Rats: Effects of Eplerenone. Circulation, 106, 2848-2853. https://doi.org/10.1161/01.CIR.0000039328.33137.6C
|
[29]
|
Munakata, M. (2014) Brachial-Ankle Pulse Wave Velocity in the Measurement of Arterial Stiffness: Recent Evidence and Clinical Applications. Current Hypertension Reviews, 10, 49-57. https://doi.org/10.2174/157340211001141111160957
|
[30]
|
Corretti, M.C., Anderson, T.J., Benjamin, E.J., et al. (2002) Guidelines for the Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery: A Report of the International Brachial Artery Reactivity Task Force. Journal of the American College of Cardiology, 39, 257-265. https://doi.org/10.1016/S0735-1097(01)01746-6
|
[31]
|
Strauch, B., Petrák, O., Zelinka, T., et al. (2008) Adrenalectomy Improves Arterial Stiffness in Primary Aldosteronism. American Journal of Hypertension, 21, 1086-1092. https://doi.org/10.1038/ajh.2008.243
|
[32]
|
Lin, Y.H., Lin, L.Y., Chen, A., et al. (2012) Adrenalectomy Improves Increased Carotid Intima-Media Thickness and Arterial Stiffness in Patients with Aldosterone Producing Adenoma. Atherosclerosis, 221, 154-159. https://doi.org/10.1016/j.atherosclerosis.2011.12.003
|
[33]
|
Ambrosino, P., Lupoli, R., Tortora, A., et al. (2016) Cardiovascular Risk Markers in Patients with Primary Aldosteronism: A Systematic Review and Meta-Analysis of Literature Studies. International Journal of Cardiology, 208, 46-55. https://doi.org/10.1016/j.ijcard.2016.01.200
|
[34]
|
Chang, C.H., Hu, Y.H., Tsai, Y.C., et al. (2017) Arterial Stiffness and Blood Pressure Improvement in Aldosterone-Producing Adenoma Harboring KCNJ5 Mutations after Adrenalectomy. Oncotarget, 8, 29984-29995. https://doi.org/10.18632/oncotarget.16269
|
[35]
|
Chang, Y.Y., Pan, C.T., Chen, Z.W., et al. (2021) KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated with a Greater Recovery of Arterial Stiffness. Cancers, 13, Article 4313. https://doi.org/10.3390/cancers13174313
|
[36]
|
Kishimoto, S., Oki, K., Maruhashi, T., et al. (2023) KCNJ5 Mutation Is a Predictor for Recovery of Endothelial Function after Adrenalectomy in Patients with Aldosterone-Producing Adenoma. Hypertension Research, 46, 2213-2227. https://doi.org/10.1038/s41440-023-01375-y
|
[37]
|
Watanabe, D., Morimoto, S., Morishima, N., et al. (2021) Clinical Impacts of Endothelium-Dependent Flow-Mediated Vasodilation Assessment on Primary Aldosteronism. Endocrine Connections, 10, 578-587. https://doi.org/10.1530/EC-21-0057
|
[38]
|
Lee, B.C., Kang, V.J., Pan, C.T., et al. (2022) KCNJ5 Somatic Mutation Is Associated with Higher Aortic Wall Thickness and Less Calcification in Patients with Aldosterone-Producing Adenoma. Frontiers in Endocrinology, 13, Article 830130. https://doi.org/10.3389/fendo.2022.830130
|
[39]
|
Chen, K.M., Chang, Y.L., Wu, T.H., et al. (2021) Aldosterone-Producing Adenoma-Harbouring KCNJ5 Mutations Is Associated with Lower Prevalence of Metabolic Disorders and Abdominal Obesity. Journal of Hypertension, 39, 2353-2360. https://doi.org/10.1097/HJH.0000000000002948
|
[40]
|
Peng, K.Y., Liao, H.W., Chan, C.K., et al. (2020) Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success. Hypertension, 76, 1537-1544. https://doi.org/10.1161/HYPERTENSIONAHA.120.15328
|